Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Diabetes Research and Clinical Practice|September 3, 2003
Increased concentration of pentosidine, an advanced glycation end product, and interleukin-6 in the vitreous of patients with proliferative diabetic retinopathyNaoto Nakamura, Goji Hasegawa, Hiroshi Obayashi, et al.
Digestive Diseases (Basel, Switzerland)|October 22, 2015
Usefulness of Cytokeratin-18M65 in Diagnosing Non-Alcoholic Steatohepatitis in Japanese PopulationYutaka Hasegawa, Soo Ryang Kim, Takashi Hatae, et al.
Biological & Pharmaceutical Bulletin|July 31, 2022
Purification of Emu IgY for Therapeutic and Diagnostic Use Based on Monoclonal Secondary Antibodies Specific to Emu IgYKouya Yamaki, Kiyoe Ohta, Norihiro Kobayashi, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 22, 2006
Relationship between insulin resistance and inflammatory markers and anti-inflammatory effect of losartan in patients with type 2 diabetes and hypertensionHyohun Park, Goji Hasegawa, Hiroshi Obayashi, et al.
Journal of Gastroenterology|July 27, 2010
Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver diseaseHyohun Park, Toshihide Shima, Kanji Yamaguchi, et al.
Human Immunology|February 1, 2003
TNF, TNF receptor type 1, and allograft inflammatory factor-1 gene polymorphisms in Japanese patients with type 1 diabetesMasataka Nishimura, Hiroshi Obayashi, Ikuko Mizuta, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 23, 2003
Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetesAya Fujinami, Hiroshi Obayashi, Kiyoe Ohta, et al.
Clinical Immunology (Orlando, Fla.)|December 13, 2006
Relationship of serum brain-derived neurotrophic factor level with other markers of disease severity in patients with atopic dermatitisKenji Namura, Goji Hasegawa, Masato Egawa, et al.
Pageof 9